Press Releases

GfK Strategic Marketing Names New President

Brian Hull, Experienced Pharmaceutical Marketing Researcher and Proven Leader Succeeds Retired President Marty Glogowski

BALA CYNWYD, PA, February 22, 2007 — GfK Strategic Marketing, a leading provider of custom healthcare marketing research, recently named Brian Hull, M.B.A., as President. Hull takes on the leadership role following the departure of Marty Glogowski, who led the firm since it became part of the GfK U.S. Healthcare Companies nearly two years ago, and last month announced his retirement.

“I am honored for this opportunity to follow in Marty’s footsteps and to be part of an organization like GfK Strategic Marketing – a company I have always admired and respected,” said Hull. “Having spent the last 15 years involved in different facets of pharmaceutical marketing research, I am thrilled to be taking this next step in my career.”

Hull has worked in all aspects of global primary marketing research in the pharmaceutical industry. He has spent the last five years working at GfK Strategic Marketing’s sister company, GfK V2, as an Executive Vice President, where he successfully grew and led a strategic business unit. Last year, Medical, Marketing & Media honored Hull as an industry "rising star" – one of 15 professionals (and the only pharmaceutical marketing researcher) to be selected as the medical marketing industry's most valuable prospects.

Prior to working at GfK V2, Hull spent the early part of his career at Migliara/Kaplan Associates, a global primary pharmaceutical marketing research company, where he became a Senior Vice President and led multiple strategic business units.

He also played a critical role in the successful development of a start-up Internet primary marketing research firm, where he was responsible for business development and led the creation of a new Internet sales force and message effectiveness methodology. Brian holds a Masters in Business Administration from Indiana University.

About GfK Strategic Marketing

For more than 25 years, GfK Strategic Marketing has been designing customized marketing research studies and methodologies to help pharmaceutical clients reduce their decision-making risk and make smart commercial decisions about their products and business. With a full range of quantitative and qualitative services, as well as worldwide research capabilities, GfK Strategic Marketing develops innovative strategies to resolve clients’ most challenging marketing research issues. GfK Strategic Marketing, along with GfK Market Measures and GfK V2, is a member of the GfK U.S Healthcare Companies - the largest custom healthcare marketing research provider in the United States.